Q. HCMI (Human Cancer Models Initiative) 란 무엇인가요?
HCMI는 유전자와 임상 데이터를 기반으로 차세대 Cancer Model (human tumor-derived culture model)을 개발하기 위해 설립된 국제 컨소시움으로, 현재 National Cancer Institute (NCI), Hubrecht Organoid Technology (HUB), Cancer Research UK (CRUK), Wellcome Sanger Institute (WSI) 등의 기관이 참여하고 있습니다.
연구 개발된 HCMI 모델과 데이터는 전 세계 모든 과학자들이 이용할 수 있도록 제공되며, ATCC는 개발된 HCMI 모델의 생산, 품질 검증, 보존 및 공급을 담당하고 있는 세계 유일 기관입니다.
현재 약 300 종 이상의 다양한 환자 조직 유래의 2-D & 3-D (오가노이드, 스페로이드 & conditionally reprogrammed cells 등) 모델이 제공되고 있으며, 희귀암의 경우도 HCMI 컨소시움이 보유한 수많은 환자 샘플들을 통해 모델로 개발 중입니다. HCMI 모델은 기존의 단순 세포 배양, 동물 실험 모델의 한계를 넘어 암의 새로운 연구법, 환자 맞춤 치료법의 개발 그리고 translational cancer research 등 다양한 분야에 유용하게 사용될 수 있습니다.
ATCC® No. | Growth Kit Name | ATCC® No. | Growth Kit Name | |
ACS-7100™ |
Organoid Growth Kit 1A Noggin 25 ug |
ACS-7103™ |
Organoid Growth Kit 1D Noggin 25 ug |
|
ACS-7101™ |
Organoid Growth Kit 1B Noggin 25 ug |
ACS-7104™ |
Organoid Growth Kit 1E Noggin 25 ug |
|
ACS-7102™ |
Organoid Growth Kit 1C Noggin 12.5 ug |
ACS-7105™ |
Organoid Growth Kit 1F Noggin 25 ug |
|
ACS-7106™ |
Organoid Growth Kit 1G EGF 12.5 ug |
Cat#를 클릭하면 대표 제품 페이지로 연결됩니다.
Tissue of Origin | Morphology | Disease | ATCC® No. |
Ampulla Of Vater | Organoid | Cancer | PDM-369™, PDM-445™ |
Ampulla Of Vater | Organoid | Carcinoma | PDM-218™, PDM-102™ |
Bone | 2-D adherent | Osteosarcoma | PDM-114™ |
Bone; Metastatic Site: Bone | 2-D adherent | Metastatic: bone cancer | PDM-227™ |
Bone; Metastatic Site: Pleural Cavity | 2-D adherent | Ewing sarcoma | PDM-125™ |
Bone; Metastatic Site: Pleural Cavity | Mixed: adherent and suspension | Ewing sarcoma | PDM-113™ |
Brain | 2-D adherent | Glioblastoma | PDM-16™, PDM-17™, PDM-19™, PDM-20™, PDM-21™, PDM-23™, PDM-109™, PDM-117™, PDM-121™, PDM-122™, PDM-132™, PDM-141™, PDM-143™, PDM-144™, PDM-147™, PDM-148™, PDM-149™, PDM-153™ PDM-228™, PDM-235™, PDM-242™, PDM-244™, PDM-245™, PDM-297™, PDM-381™, PDM-400™, PDM-402™, PDM-403™, PDM-471™, PDM-472™, PDM-475™, PDM-499™, PDM-501™, PDM-502™, PDM-503™ |
Brain | Mixed: adherent and suspension | Glioblastoma | PDM-22™, PDM-18™, PDM-123™, PDM-140™, PDM-299™, PDM-300™, PDM-301™, PDM-302™, PDM-320™, PDM-505™ |
Brain | Neurosphere | Glioblastoma | PDM-378™, PDM-379™ |
Brain | 3-D other | Glioblastoma | PDM-504™ |
Breast | Organoid | Cancer | PDM-92™, PDM-195™, PDM-250™, PDM-350™ |
Colon | Organoid | Adenocarcinoma | PDM-1™, PDM-45™, PDM-50™, PDM-51™, PDM-57™, PDM-59™, PDM-60™, PDM-61™, PDM-64™, PDM-94™, PDM-95™, PDM-183™, PDM-184™, PDM-185™, PDM-186™, PDM-188™, PDM-256™ |
Colon | Organoid | Adenoma | PDM-48™ |
Colon | Organoid | Cancer | PDM-46™, PDM-53™, PDM-58™, PDM-255™, PDM-276™, PDM-277™, PDM-356™, PDM-357™, PDM-359™, PDM-363™, PDM-364™, PDM-420™, PDM-422™, PDM-513™ |
Colon; Metastatic Site: Brain | Mixed: adherent and suspension | Adenocarcinoma | PDM-104™, PDM-386™ |
Colon; Metastatic Site: Colon | Organoid | Adenocarcinoma | PDM-275™ |
Colon; Metastatic Site: Liver | Organoid | Adenocarcinoma | PDM-42™ |
Colorectal | Organoid | Adenoma | PDM-279™ |
Colorectal | Organoid | Cancer | PDM-274™ |
Connective tissue | 2-D adherent | Primary Desmoid Tumor | PDM-625™ |
Endometrium | Organoid | Cancer | PDM-528™, PDM-587™ |
Epithelial | 2-D adherent | Epithelioid sarcoma | PDM-229™, PDM-236™ |
Esophagus | Organoid | Adenocarcinoma | PDM-68™, PDM-70™, PDM-71™, PDM-74™, PDM-75™, PDM-76™, PDM-77™, PDM-78™, PDM-80™, PDM-81™, PDM-82™, PDM-83™, PDM-84™, PDM-85™, PDM-86™, PDM-124™, PDM-131™, PDM-159™ |
Esophagus | Organoid | Cancer | PDM-65™, PDM-67™, PDM-72™, PDM-73™, PDM-79™, PDM-87™, PDM-120™, PDM-225™, PDM-243™, PDM-339™, PDM-469™, PDM-512™ |
Esophagus; Metastatic Site: Esophagus | Mixed: adherent and suspension | Cancer | PDM-246™ |
Esophagus; Metastatic Site: Liver | Organoid | Cancer | PDM-119™ |
Esophagus; Metastatic Site: Peritoneum | Organoid | Cancer | PDM-470™ |
Esophagus; Metastatic Site: Pleural Cavity | Organoid | Cancer | PDM-158™ |
Esophagus; Metastatic Site: Stomach | Organoid | Cancer | PDM-490™ |
Extrahepatic Bile Duct | Organoid | Adenocarcinoma | PDM-216™, PDM-217™, PDM-220™ |
Gall bladder: IPMN | Organoid | Benign neoplasm premalignant | PDM-273™ |
Head and Neck | Organoid | Cancer | PDM-428™ |
Kidney | 2-D adherent | Wilms tumor | PDM-115™, PDM-182™ |
Large intestine; Rectum | Organoid | Adenocarcinoma | PDM-49™ |
Liver | Organoid | Cholangiocarcinoma | PDM-219™ |
Lung | 2-D adherent | Cancer | PDM-305™ |
Lung | Organoid | Adenocarcinoma | PDM-3™ |
Lung | Organoid | Cancer | PDM-683™, PDM-685™ |
Lung, Derived From Metastatic Site: Brain | Mixed: adherent and suspension | Cancer | PDM-112™, PDM-154™ |
Malignant neoplasm of thyroid; metastatic site: pleural fluid | 2-D adherent | Malignant Neoplasm | PDM-662™ |
Ovary | Organoid | Cancer | PDM-514™, PDM-515™ |
Pancreas | Organoid | Adenocarcinoma | PDM-25™, PDM-26™, PDM-27™, PDM-28™, PDM-29™, PDM-32™, PDM-33™, PDM-34™, PDM-35™, PDM-36™, PDM-38™, PDM-39™, PDM-40™, PDM-41™, PDM-101™, PDM-108™, PDM-110™, PDM-126™, PDM-134™ PDM-137™, PDM-138™, PDM-168™, PDM-169™, PDM-179™, PDM-197™, PDM-200™, PDM-201™, PDM-204™, PDM-221™, PDM-222™, PDM-289™ |
Pancreas | Organoid | Cancer | PDM-24™, PDM-30™, PDM-37™, PDM-31™, PDM-90™, PDM-198™, PDM-203™, PDM-205™, PDM-270™, PDM-421™, PDM-423™ |
Pancreas: Metastatic Site: Liver | Organoid | Adenocarcinoma | PDM-106™ |
Pancreas: Metastatic Site: Liver | Organoid | Cancer | PDM-107™, PDM-288™ |
Pancreas; Metastatic Site: Lymph Node | Organoid | Cancer | PDM-223™ |
Pancreas; Metastatic Site: Peritoneum | Organoid | Adenocarcinoma | PDM-164™ |
Pancreas; Metastatic Site: Pleural Cavity | Organoid | Adenocarcinoma | PDM-170™ |
Rectosigmoid Junction | Organoid | Adenocarcinoma | PDM-6™, PDM-100™, PDM-264™ |
Rectum | Organoid | Adenocarcinoma | PDM-43™, PDM-47™, PDM-55™ PDM-62™, PDM-63™, PDM-96™ |
Rectum | Organoid | Adenoma | PDM-44™ |
Rectum | Organoid | Cancer | PDM-9™, PDM-97™, PDM-103™, PDM-190™, PDM-191™, PDM-254™, PDM-257™, PDM-258™, PDM-263™, PDM-330™, PDM-331™ |
Sigmoid Colon | Organoid | Adenocarcinoma | PDM-2™, PDM-4™, PDM-5™, PDM-7™, PDM-8™ |
Skin | 2-D adherent | Melanoma | PDM-281™, PDM-282™, PDM-384™, PDM-392™, PDM-395™, PDM-473™, PDM-478™, PDM-481™, PDM-484™, PDM-487™, PDM-494™, PDM-498™ |
Skin | 2-D adherent | Melanoma; Metastatic | PDM-485™ |
Skin; Metastatic Site: Lymph Node | 2-D adherent | Melanoma | PDM-284™, PDM-285™, PDM-291™, PDM-293™, PDM-294™, PDM-313™, PDM-319™, PDM-387™, PDM-388™ |
Skin; Metastatic Site: Skin | 2-D adherent | Melanoma | PDM-292™, PDM-389™ |
Small Intestine | Organoid | Adenoma | PDM-368™ |
Small Intestine | Organoid | Cancer | PDM-272™, PDM-374™ |
Soft Tissue; Metastatic Site: Pleural Cavity | 2-D adherent | Rhabdomyosarcoma | PDM-238™, PDM-290™ |
Soft Tissue; Metastatic Site: Pleural Cavity | Mixed: adherent and suspension | Rhabdomyosarcoma | PDM-129™ |
Soft Tissue; Metastatic Site: Soft Tissue | 2-D adherent | Epithelioid sarcoma | PDM-230™ |
Soft Tissue; Metastatic Site: Soft Tissue | 2-D adherent | Malignant Neoplasm | PDM-609™ |
Stomach | Organoid | Adenocarcinoma | PDM-136™, PDM-162™, PDM-233™ |
Stomach | Organoid | Cancer | PDM-146™, PDM-226™, PDM-308™, PDM-315™, PDM-316™, PDM-376™, PDM-377™, PDM-519™ |
Stomach | Organoid | Cancer; Metastatic | PDM-323™, PDM-489™ |
Stomach; Metastatic Site: Lymph Node | Organoid | Adenocarcinoma | PDM-135™ |
Stomach; Metastatic Site: Pleural Cavity | Organoid | Cancer | PDM-161™ |
Stomach; Metastatic Site: Pleural Cavity | Organoid | Adenocarcinoma | PDM-116™ |
Stomach; Metastatic Site: Pleural Cavity | Mixed: adherent and suspension | Cancer | PDM-163™ |
HCMI 모델 및 오가노이드 growth kits 자료는 아래에서 다운로드 받으실 수 있습니다.